Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

被引：0
|
作者：
David A Palma
Cornelis J A Haasbeek
George B Rodrigues
Max Dahele
Michael Lock
Brian Yaremko
Robert Olson
Mitchell Liu
Jason Panarotto
GwendolynHMJ Griffioen
Stewart Gaede
Ben Slotman
Suresh Senan
机构：
[1] London Regional Cancer Program,Department of Radiation Oncology
[2] VU University Medical Center,Department of Radiation Oncology
[3] British Columbia Cancer Agency,Department of Radiation Oncology
[4] Ottawa Regional Cancer Centre,Department of Radiation Oncology
来源：
BMC Cancer | / 12卷
关键词：
Oligometastases; Stereotactic radiotherapy; Quality of life; Cancer; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
    Cole, Suzanne
    Kim, Se Eun
    Wentland, Andrew
    Lin, Mu-Han
    Kapur, Payal
    Wulff-Burchfield, Elizabeth Marie
    Shevrin, Daniel
    Gurley, Tami
    Lin, John C.
    Wagner, Lynne I.
    McKay, Rana R.
    Brugarolas, James
    Qin, Qian
    Gunter, Tyler
    Kyriakopoulos, Christos
    Harichand-Herdt, Seema
    Sykes, Glenn
    Haas, Naomi Balzer
    Carducci, Michael A.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS615 - TPS615
  • [22] Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
    Kim, Se Eun
    Cole, Suzanne
    Wulff-Burchfield, Elizabeth Marie
    Wentland, Andrew
    Hannan, Mu-Han
    Kapur, Payal
    Shevrin, Daniel
    Gurley, Tami
    Lin, John Kent
    Brugarolas, James
    Timmerman, Robert D.
    Mckay, Rana R.
    Wagner, Lynne I.
    Haas, Naomi B.
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : TPS489 - TPS489
  • [23] Cost effectiveness of stereotactic ablative radiotherapy (SABR) alone in comparison with systemic treatment and SABR in oligometastatic head and neck cancer in the GORTEC 2014-04 OMET randomized phase II study
    Thariat, J.
    Falcoz, A.
    Nadin, L.
    Bourhis, J.
    Sun, X.
    Nerich, V.
    ANNALS OF ONCOLOGY, 2024, 35 : S634 - S634
  • [24] Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
    Harrow, Stephen
    Palma, David A.
    Olson, Robert
    Gaede, Stewart
    V. Louie, Alexander
    Haasbeek, Cornelis
    Mulroy, Liam
    Lock, Michael
    Rodrigues, George B.
    Yaremko, Brian P.
    Schellenberg, Devin
    Ahmad, Belal
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Schlijper, Roel
    Bauman, Glenn S.
    Laba, Joanna
    Qu, X. Melody
    Warner, Andrew
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 611 - 616
  • [25] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
    Jiang, W. N.
    Baker, S.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Chan, E. K.
    Mohamed, I. G.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Lefresne, S.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S147 - S148
  • [26] Cost-minimization analysis of the GORTEC 2014-04 randomized phase II study of stereotactic ablative radiotherapy (SABR) or chemotherapy-SABR in oligometastatic head and neck cancer
    Nerich, Virginie
    Falcoz, Antoine
    Nadin, Lawrence
    Meurisse, Aurelia
    Pechery, Adeline
    Bourhis, Jean
    Sun, Xu-Shan
    Thariat, Juliette
    RADIOTHERAPY AND ONCOLOGY, 2025, 204
  • [27] COST-EFFECTIVENESS OF SABR IN OLIGOMETASTATIC CANCER: AN ECONOMIC ANALYSIS BASED ON LONG-TERM RESULTS OF THE SABR-COMET RANDOMIZED TRIAL
    Qu, Melody
    Chen, Yujie
    Zaric, Gregory
    Senan, Suresh
    Olson, Robert
    Harrow, Stephen
    John-Baptiste, Ava
    Gaede, Stewart
    Mulroy, Liam
    Schellenberg, Devin
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Warner, Andrew
    Rodrigues, George
    Palma, David
    Louie, Alexander
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S13 - S13
  • [28] Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study
    Choi, Seo Hee
    Lee, Byung min
    Kim, Jina
    Kim, Do Young
    Seong, Jinsil
    JOURNAL OF HEPATOLOGY, 2024, 81 (01) : 84 - 92
  • [29] A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR)
    Gensheimer, M. F.
    Gee, H. E.
    Von Eyben, R.
    Shirato, H.
    Taguchi, H.
    Wong, S.
    Brown, E.
    Nguyen, N.
    Liang, R.
    Maxim, P. G.
    Wakelee, H. A.
    Neal, J. W.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S89 - S90
  • [30] Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
    David, Steven
    Tan, Jennifer
    Savas, Peter
    Bressel, Mathias
    Kelly, Dianne
    Foroudi, Farshad
    Loi, Sherene
    Siva, Shankar
    BREAST, 2020, 49 : 55 - 62
12345